NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 280000000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2024-12-31)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2026-03-31
Retrieved: 2026-08-23T22:32:52.133018+02:00
Raw response sha256: 26b25d5260a1f348b77d6b5c2a54e9db…
Cite as: FACTANKER, https://factanker.com/fact/13c6a43c-b951-4540-aa8a-8f7bfa93df5b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies